Study of External Drainage of Pancreatic and Bile Ducts to Reduce Pancreatic Fistula After Pancreaticoduodenectomy Surgery
Led by Shanghai Zhongshan Hospital · Updated on 2025-01-22
322
Participants Needed
1
Research Sites
35 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are studying the effects of external drainage of the main pancreatic duct and common bile duct on postoperative complications, especially pancreatic fistula, following pancreaticoduodenectomy PD. PD is a common surgery for tumors in the pancreatic head, distal bile duct, duodenum, and ampulla of Vater. Although mortality rates have decreased in experienced centers, complications like pancreatic fistula, delayed gastric emptying, and biliary leakage remain frequent and serious concerns. This trial aims to clarify whether external drainage reduces these complications compared to internal drainage, especially in patients at intermediate or high risk of pancreatic fistula.
The study compares two surgical methods after PD external drainage using patented silicone tubes with one-way valves for both the pancreatic and biliary ducts, and internal drainage involving sutured anastomoses with stents in the pancreatic duct and bile duct. Each method involves detailed surgical techniques to connect the pancreatic and bile ducts to the jejunum. Participants will be randomly assigned to one of these two groups to assess differences in postoperative outcomes.
Participants will be followed for 90 days after surgery to monitor the occurrence of clinically relevant pancreatic fistula and other complications such as bleeding, infection, and delayed gastric emptying. Researchers will also track hospital stay length, treatment costs, reoperation and readmission rates, and long-term survival up to five years. Assessments include clinical evaluations and complication grading to understand the safety and impact of each drainage approach.
CONDITIONS
Brief Title
Impact of External Drainage of the Main Pancreatic Duct and Common Bile Duct on Pancreatic Fistula Following Pancreaticoduodenectomy
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
ECOG performance status of 0 or 1 with life expectancy of at least 12 weeks and ASA score 2 or less
Clinical diagnosis of tumors in the pancreatic head, ampulla of Vater, duodenum, or distal common bile duct requiring pancreaticoduodenectomy
No serious dysfunction in blood system, heart, lung, or autoimmune system
White blood cell count at least 3 x 10^9/L; absolute neutrophil count at least 1.5 x 10^9/L; platelets at least 100 x 10^9/L; hemoglobin at least 90 g/L
Liver enzymes (AST/ALT) not exceeding 2.5 times institutional upper limit; total bilirubin within normal limits; creatinine not exceeding 1.5 times upper limit
Prothrombin time and INR not exceeding 1.5 times upper limit
Able to follow visit schedules and protocol requirements
Intermediate or high risk of postoperative pancreatic fistula according to scoring system
You will not qualify if you...
Advanced cancer with distant metastasis or invasion of major blood vessels
Congestive heart failure with NYHA class 3 or 4
Uncontrolled hypertension
Renal failure requiring dialysis
Serious active infection above grade 2
Pregnant or breastfeeding women
Major surgery within 4 weeks before trial or not fully recovered from previous surgery
Other active malignant tumors unless cured for 3 years or more
Recent upper gastrointestinal bleeding within 4 weeks or ongoing bleeding risk
Poor compliance or unwillingness to sign informed consent
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Surgery and Immediate Post-operative Care
Duration - Hospital stay averaging 2 weeks
Participants undergo pancreaticoduodenectomy surgery with either external or internal drainage of the main pancreatic and biliary ducts as part of the procedure.
Approximately 1 surgical procedure and hospital care period
Post-operative Follow-up
Duration - Up to 90 days after surgery
Participants are monitored for surgical complications, including pancreatic fistula and other post-operative outcomes, up to 90 days after surgery.
Follow-up visits during the 90 days post-surgery as scheduled
Long-term Monitoring
Duration - Up to 60 months after surgery
Participants with malignant tumors are followed up for overall survival and disease-free survival for up to 60 months after surgery.
Periodic long-term follow-up visits up to 5 years
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Comparing Total Laparoscopic and Open Pancreaticoduodenectomy Surgery for Pancreatic Cancer in a Multicenter Randomized Trial
Observing Energy Needs and Nutritional Support After Pancreatic Surgery for Tumor Recovery in Adults
Study of External Drainage of Pancreatic and Bile Ducts to Reduce Pancreatic Fistula After Pancreaticoduodenectomy Surgery
Randomized Trial of N-Butyl-2-Cyanoacrylate Injection to Improve Pancreaticojejunostomy Outcomes After Pancreaticoduodenectomy
Phase 2 Study of Preoperative Radiotherapy to Prevent Pancreatic Fistula After Pancreaticoduodenectomy Surgery
New Technique Using N-Butyl-2-Cyanoacrylate Injection During Pancreaticoduodenectomy to Improve Pancreaticojejunostomy Safety and Reduce Fistula Risk
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Impact of external drainage of the main pancreatic duct and common bile duct on postoperative pancreatic fistula following pancreatoduodenectomy: protocol for a multicentre randomized clinical trial.